COX5B has been reported as a growth-promoting gene that modulates downstream pathways in response to the induced bioenergetic alterations in HCC, breast cancer, and glioma, but its role in CRCs remains unknown [24,29,30,31]. The gene discussed is COX5B; the disease is glioma.